Consistent with these results, in the nude mouse xenograft model, we overexpressed HA-RAD52 and knocked down SRSF11 and found that knocking down SRSF11 significantly inhibited tumor growth in vivo compared with that in the control group (Fig. 5e, f). This evidence concerns the gene RAD52 and neoplasm.